These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
599 related articles for article (PubMed ID: 27213345)
1. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Leopold JA; Maron BA Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213345 [TBL] [Abstract][Full Text] [Related]
2. microRNA and Pulmonary Hypertension. Boucherat O; Potus F; Bonnet S Adv Exp Med Biol; 2015; 888():237-52. PubMed ID: 26663186 [TBL] [Abstract][Full Text] [Related]
3. [Advances in molecular mechanism of vascular remodeling in pulmonary arterial hypertension]. Xiao L; Tong X Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 May; 48(1):102-110. PubMed ID: 31102364 [TBL] [Abstract][Full Text] [Related]
4. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension. Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276 [TBL] [Abstract][Full Text] [Related]
6. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Orriols M; Gomez-Puerto MC; Ten Dijke P Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104 [TBL] [Abstract][Full Text] [Related]
7. Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension. Ten Freyhaus H; Berghausen EM; Janssen W; Leuchs M; Zierden M; Murmann K; Klinke A; Vantler M; Caglayan E; Kramer T; Baldus S; Schermuly RT; Tallquist MD; Rosenkranz S Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1236-45. PubMed ID: 25745058 [TBL] [Abstract][Full Text] [Related]
8. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling. Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656 [TBL] [Abstract][Full Text] [Related]
9. The emerging role of microRNAs in hypoxia-induced pulmonary hypertension. Mohsenin V Sleep Breath; 2016 Sep; 20(3):1059-67. PubMed ID: 27154628 [TBL] [Abstract][Full Text] [Related]
10. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension. Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990 [TBL] [Abstract][Full Text] [Related]
11. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling. Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in pulmonary arterial remodeling. Grant JS; White K; MacLean MR; Baker AH Cell Mol Life Sci; 2013 Dec; 70(23):4479-94. PubMed ID: 23739951 [TBL] [Abstract][Full Text] [Related]
13. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway. Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255 [TBL] [Abstract][Full Text] [Related]
14. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model. Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980 [TBL] [Abstract][Full Text] [Related]